Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GOVX save search
GeoVax Receives Notice of Allowance for Zika Vaccine Patent
Published: 2023-01-25 (Crawled : 20:00) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: -2.66%
H: 104.41%
C: 63.24%
patent vaccine
GeoVax to Report Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 and Provide Corporate Update
Published: 2022-07-26 (Crawled : 16:00) - biospace.com/
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: 3.77%
H: 50.3%
C: 3.03%
report update results
GeoVax Announces Closing of $10.3 Million Bought Deal Offering
Published: 2021-02-11 (Crawled : 19:01) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: -0.42%
H: 21.14%
C: 4.03%
offering
GeoVax’s Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patients
Published: 2023-05-24 (Crawled : 12:00) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: 1.99%
H: 14.79%
C: 11.94%
covid-19 vaccine
GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress
Published: 2023-11-28 (Crawled : 14:00) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: -2.52%
H: 14.22%
C: 5.39%
covid-19 vaccine congress world
GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules
Published: 2022-05-25 (Crawled : 18:00) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: 4.37%
H: 13.81%
C: -30.13%
nasdaq market
GeoVax to Report Second Quarter 2023 Financial Results and Provide Corporate Update on Wednesday, August 9, 2023
Published: 2023-07-26 (Crawled : 13:20) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: -0.18%
H: 12.45%
C: 11.82%
report update financial results
GeoVax Announces Issuance of Ebola Vaccine Patent
Published: 2023-07-24 (Crawled : 13:00) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: 8.93%
H: 11.92%
C: -6.34%
patent ebola vaccine
GeoVax Universal Coronavirus Vaccine Design & Development Approach Published in Vaccine Insights
Published: 2023-06-27 (Crawled : 14:20) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: 0.0%
H: 9.7%
C: -2.05%
vaccine universal
GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024
Published: 2023-12-27 (Crawled : 14:00) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: 2.74%
H: 9.33%
C: -0.53%
biotech week
GeoVax to Present at the 2023 BIO CEO & Investor Conference
Published: 2023-01-26 (Crawled : 14:00) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: -9.91%
H: 8.96%
C: -24.89%
ceo conference
GeoVax Receives Notice of Allowance for HIV Vaccine Patent
Published: 2023-10-05 (Crawled : 13:30) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: 2.02%
H: 8.86%
C: 3.45%
patent vaccine hiv
GeoVax to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress
Published: 2022-04-12 (Crawled : 13:20) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: -1.87%
H: 7.62%
C: 0.0%
vaccine
GeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS Head and Neck Cancer Conference
Published: 2023-07-10 (Crawled : 13:20) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: -0.8%
H: 6.95%
C: 3.39%
gedeptin conference cancer
GeoVax Announces Addition to Its Board of Directors
Published: 2022-09-01 (Crawled : 13:20) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: -5.04%
H: 6.19%
C: 0.88%
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development
Published: 2023-09-26 (Crawled : 13:00) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: -0.29%
H: 5.69%
C: 0.2%
pix vaccine license cell
GeoVax to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 9, 2022
Published: 2022-10-26 (Crawled : 13:20) - biospace.com/
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: 21.3%
H: 5.66%
C: 4.72%
conference financial update results
GeoVax to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-07 (Crawled : 14:20) - biospace.com/
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: -3.64%
H: 5.66%
C: 0.0%
global conference
GeoVax CEO Selected as a Recipient of the 2022 Georgia Titan 100
Published: 2022-02-22 (Crawled : 19:00) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: -1.12%
H: 5.65%
C: -2.26%
ceo 100
GeoVax Announces Gedeptin® Presentation at the AACR-AHNS Head and Neck Cancer Conference
Published: 2023-06-28 (Crawled : 13:00) - globenewswire.com
GOVX | $1.59 4.61% 4.4% 19K
|
Health Technology
|
| O: 0.22%
H: 5.51%
C: 0.58%
gedeptin conference presentation cancer
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.